by Katie Nightingale | Feb 2, 2023 | Research
In the last 30 years there has been very little change to osteosarcoma (OS) treatment. We are dedicated to changing this. Through the Myrovlytis Trust, we fund research into OS, with a focus on finding new treatments. We are pleased to announce we have awarded funding...
by Jazzmin Huber | Jan 13, 2023 | Research, Resources and Support
Our work in osteosarcoma (OS) started in 2021, with many months dedicated to talking with experts, patients and other charities. These initial conversations helped us to identify how best we could support patients and their families. 2022 was the year we made these...
by Jazzmin Huber | Dec 6, 2022 | Clinical Trials, Research
In November 2022 we attended the Connective Tissue Oncology Society (CTOS) meeting. This meeting brought together clinicians, researchers and patient advocates dedicated to improving outcomes in sarcoma. In this blog we highlight some of the talks with a focus on...
by Jazzmin Huber | Nov 29, 2022 | Research
To treat osteosarcoma (OS), surgeons will often remove the bone containing the tumour. This bone can then be replaced with a metal implant. A recent study looked at whether implants made of carbon-fibre could be an alternative to metal. Metal Implants Metal is the...
by Katie Nightingale | Nov 22, 2022 | Research
There is an urgent need to find new therapies in osteosarcoma (OS) that has spread or has not responded to standard treatment. Identifying new treatments can be a long and complex process. One method of speeding up the process is to use drugs that already approved to...
by Katie Nightingale | Nov 15, 2022 | Research
There is a great need to develop new treatments for osteosarcoma (OS). This is particularly true for OS that has spread or has not responded to current standard therapy. Researchers are actively working towards finding new drugs to treat OS. To enable the drug...